Planta Medica · 2013 · 12 citations · 0 references
Life SciencesBotanyPharmacologyInflammationInnate ImmunityPlant BiochemistryAnti-inflammatory PharmacologyInflammation PharmacologyMedicinal Plant KnowledgeMedicinal PlantsAnti-inflammatory ActivityAnti-inflammatory Drug MechanismsAnti-inflammatory Natural ProductsAnti-inflammatory ResponseCox ProcessesNf-κb SignalingPlant AlkaloidsTraditional Chinese Medicine
3-(Hydroxymethyl)-6,7-dihydroindolo[2,3-a]quinolizin-(12H)-one is a bioactive indole alkaloid isolated from <i>Nauclea officinalis</i>, a plant species which is used as a traditional Chinese medicine. We investigated the anti-inflammatory properties of 3-(hydroxymethyl)-6,7-dihydroindolo[2,3-a]quinolizin-(12H)-one in RAW 264.7 murine macrophages. The results indicated that it inhibited the overproduction of NO and the release of TNF-<i>α</i>. Furthermore, this compound inhibited the expression of iNOS and COX-2 proteins, the enzymatic activity of iNOS, and the translocation of NF-<i>κ</i>B to the nucleus induced by LPS. Therefore, we suggested that the effect of 3-(hydroxymethyl)-6,7-dihydroindolo[2,3-a]quinolizin-(12H)-one-mediated inhibition of the expression of LPS-induced iNOS and COX-2 genes is due to the suppression of NF-<i>κ</i>B activation in the transcriptional level.